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TEST-RETEST RELIABILITY OF EVOKED HEAT STIMULATION BOLD 
FUNCTIONAL MAGNETIC RESONANCE IMAGING 
JORDAN DANIEL LEMME 
 
ABSTRACT 
To date, the blood oxygenated-level dependent (BOLD) functional magnetic 
resonance imaging (fMRI) technique has enabled an objective and deeper 
understanding of pain processing mechanisms embedded within the human 
central nervous system (CNS).  In order to further comprehend the benefits and 
limitations of BOLD fMRI in the context of pain as well as the corresponding 
subjective pain ratings, we evaluated the univariate response, test-retest 
reliability and confidence intervals (CIs) at the 95% level of both data types 
collected during evoked stimulation of 40°C (non-noxious), 44°C (mildly noxious) 
and a subject-specific temperature eliciting a 7/10 pain rating.  The test-retest 
reliability between two scanning sessions was determined by calculating group-
level interclass correlation coefficients and at the single-subject level.   
 
Across the three stimuli, we initially observed a graded response of increasing 
magnitude for both visual analogue scale (VAS) pain ratings and fMRI data.  
Test-retest reliability was observed to be highest for VAS pain ratings obtained 
during the 7/10 pain stimulation (intraclass correlation coefficient (ICC) = 0.938), 
while ICC values of pain fMRI data for a distribution of CNS structures ranged 
!! vi 
from 0.5 to 0.859 (p < 0.05).  Importantly, the upper and lower CI bounds 
reported herein could be utilized in subsequent trials involving healthy volunteers 
to hypothesize the magnitude of effect required to overcome inherent variability 
of either VAS pain ratings or BOLD responses evoked during innocuous or 
noxious thermal stimulation.  
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INTRODUCTION 
 
With blood oxygenated-level dependent (BOLD) functional magnetic resonance 
imaging (fMRI) methodology, the behavior of pain pathways structures within the 
central nervous system (CNS) has been characterized in states of acute or 
chronic pain [7; 8; 11], during therapeutic intervention [4; 18; 21] and during the 
placebo response [1; 6].  From work stemming from the pain fMRI field, it is 
better known which CNS structures can potentially be targeted, directly or 
indirectly, in order to obtain a possible analgesic effect (e.g., insula in 
fibromyalgia patients) [5].  However, despite the large body of pain fMRI work, 
there remain fundamental unknowns regarding the utility of this methodology, as 
a means to characterize pathology in distinct pain patient populations or to 
evaluate novel therapies, be they pharmacological or behavioral in nature.   One 
area believed to require further attention is a more indebt assessment of test-
retest reliability of pain fMRI experimental paradigms [9; 13].  These studies 
mainly have looked at repeated exposure of subjects to the same stimulus.  With 
test-retest reliability of pain fMRI in hand, its utility particularly during longitudinal, 
proof-of-concept clinical trials can be further realized.   
 
In this study, to better reflect a randomized clinical trial with a cross-over design 
of drug and placebo, subjects were enrolled in a drug (buprenorphine) placebo 
study, however, they only received saline injections.  We aimed to quantify the 
reproducibility of the pain fMRI method itself so that in future work, variations in 
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the BOLD fMRI signal can be more confidently attributed to inherent fluctuations 
in pain levels perceived in patients, treatment effect or a combination of the two.   
 
Across pain fMRI studies, the stimulation paradigm has indeed varied from study 
to study.  These variations derive from study site preferences as well as which 
pain stimuli may be most suitable to implement in order to probe the etiology and 
pathology of a particular patient population.  However, thermal heat pain is one 
type of evoked stimulation widely used in not only fMRI studies, but also 
behavioral work aimed solely at quantitative sensory testing (QST) in healthy 
subjects or pain patients.  To date, it is well known that thermal heat pain induces 
robust BOLD activation and deactivation in multiple ascending and descending 
pain pathway structures, which process sensory and affective components of 
pain [19].  Multiple studies have dissected the properties of the BOLD signal 
elicited by noxious thermal stimuli and in turn, have characterized what features 
(e.g., biphasic response) of the BOLD signal are specific to evoked pain [10; 12; 
19].  Moreover, cross-sectional investigations utilizing thermal heat pain have 
clearly demonstrated that a substantial dynamic range exists in the BOLD signal 
such that a treatment effect, acute or chronic, can be measured.   
 
Given the a priori knowledge of thermal pain responses as measured by BOLD 
fMRI methodology, this healthy subject study focused on a quantitative 
assessment of test-retest reliability of pain fMRI during the presence of heat 
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stimuli.  Based on the variability of what temperatures are considered painful 
from one individual to another, a subject-specific heat stimuli yielding a 7 out of 
10 rating on the visual analogue scale (VAS) was utilized.  The objective of our 
study was to further evaluate the test-retest reliability of pain fMRI by calculating 
the intraclass correlation coefficient (ICC) across CNS structures previously 
implicated in pain processing.  The ICCs across brain regions were compared for 
40°C, 44°C and subject-specific temperatures corresponding to 7/10 pain rating, 
where the latter was considered the ‘pain condition’.  Furthermore, the current 
study was carried out with the specific needs and requirements of a 
pharmacological fMRI study in mind [14; 15].  Therefore, steps enabling better 
standardization of study procedures were executed as well as onsite ‘drug’ 
administration of a placebo pill at each scan session.   
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METHODS  
 
Study Participants  !
This investigation was approved by the McLean Hospital Institutional Review 
Board  
 
Twelve healthy, right-handed male participants were included in this study (mean 
age ± standard deviation: 31 ± 8.8 years old).  Of these 12 study participants, 10 
individuals possessed complete imaging + behavioral datasets that are reported 
on herein.  Each of the 10 subjects made three study site visits (prescreen and 2 
MRI scanning sessions termed Scans 1 and 2).  The prescreen visit consisted of 
the following procedures: 1) Introduction to 40°C and 44°C stimuli (dorsum or left 
foot) in order to become familiar with the Medoc Thermal Sensory Analyzer 
(TSA) probe and stimuli itself, 2) QST to determine the subject-specific 
temperature corresponding to a 7 out of 10 pain rating on the VAS (maximum 
temperature = 50°C), 3) Training on pain reporting equipment utilized during 
fMRI, 4) Review of complete medical history and 5) Physician assessment, which 
included physiological measurements.   
 
Enrolled participants had no presence of physical or mental illness, no presence 
chronic pain disorders, consumed no medications and reported no history of 
alcoholism or drug abuse.  Subsequent to prescreening procedures, each 
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individual underwent 2 scanning sessions that were ~2-3 weeks apart.  All 
volunteers gave informed consent prior study participation.  All volunteers were 
told that they would receive either saline (placebo) or an analgesic infusion in a 
cross-over design.  After they finished participating in the study they were told 
that only saline was used. 
 
Pre-Scanning Procedures !
For each subject and each scanning session, a detailed checklist was kept to 
ensure all predefined standard operating procedures (SOP) were adhered to.  
Within this checklist, deviations from the SOP were logged (e.g., ancillary 
equipment malfunction) as well as timestamps of distinct components of the 
study (e.g., baseline vitals or start of anatomical MRI).  Drug test were first 
completed before each scan session to verify the subjects’ eligibility.  Following 
drug testing, subjects received 1) A brief re-training of VAS pain rating equipment 
and review of the study procedures, 2) Physician assessment, 3) Placement of 
an intravenous line (subjects’ left arm) for subsequent within MRI scanner blood 
draw (not actually performed) and 4) Oral drug administration (sublingual vitamin 
B-12 pill) prior to subject placement within the scanner.  Once subjects were 
positioned within the MRI monitoring of physiology (heart rate, end-tidal CO2, 
PO2, respiratory rate) was initiated.    
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Heat Stimulation !
During the fMRI scan, a mixed heat stimulation paradigm was used to assess the 
reproducibility of 40°C (non-noxious), 44°C (mildly noxious) and the subject-
specific, 7/10 noxious heat pain stimulation.  A 32 cm2 TSA thermode was 
attached to the subjects left foot via Velcro strap with a baseline temperature of 
32°C.  The stimulation paradigm consisted of 25 second off and 15 second on 
cycle where each temperature (i.e., 40°C, 44°C and 7/10) was randomly 
presented five times.  During heat stimulation and fMRI data collection, VAS pain 
ratings were continuously and simultaneously collected from the subjects.  
 
MRI Data Acquisition !
MRI data were collected on a 3 Tesla Siemens Trio scanner with an 8-channel 
phased array head coil (Erlangen, Germany).  fMRI data were collected using a 
gradient echo-echo planar pulse sequence (GE-EPI) at a 3.5 x 3.5 x 3.5 mm3 
resolution.  GE-EPI Parameters: Time of Repetition (TR) = 2500 msecs, Time of 
Echo (TE) = 30 msecs, Field of View (FOV) = 224x224, Flip Angle (FA) = 90°, # 
of Slices = 41 axial slices, # of Volumes = 283.  Magnetization-Prepared Rapid 
Acquisition Gradient-Echo (MPRAGE) anatomical images were collected. 
MPRAGE Parameters: TR = 2100 msecs, TE = 2.74 msecs, Inversion Time (TI) 
= 1100 msecs, FA = 12°, 128 sagittal slices.   
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Quality Assurance (QA) of MRI Data !
QA of all fMRI data was performed using a MatLab (MathWorks, Sherbon, MA, 
USA)-based functional Biomedical Informatics Research Network (fBIRN) 
analysis algorithm (fBIRN-qa-calc_birn.m).  Each fMRI dataset was also motion 
corrected using FSL’s McFlirt algorithm (FMRIB Software Library (FSL 5) 
(www.fmrib.ax.ac.uk/fsl)), and evaluated to determine if the maximum deviation 
due to motion was never greater than 2.5 millimeters (mm), the in-plane 
resolution utilized during fMRI data acquisition. 
  
fMRI Data Processing !
Subsequent single-subject fMRI data analyses were performed using FSL 5 [25].  
Preprocessing steps for fMRI data have been described elsewhere [17; 19].  
Moreover, a dual explanatory variable (EV) general linear model (GLM) analysis 
of single-subject fMRI data was utilized to quantify early (stimulus-locked) and 
late phase BOLD responses identified and characterized in earlier evoked pain 
fMRI work.  Within group average analyses were performed using a mixed-
effects analyses [22].  Each group average statistical map was set to a threshold 
of z > 2.3 and cluster-size corrected [16]. 
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Intraclass Correlation Coefficients and Confidence Intervals  !
To evaluate the test-retest reliability of VAS pain rating and BOLD fMRI data 
between Scans 1 and 2 and data stemming from 40°C, 44°C and 7/10 heat 
stimuli, the ICC values were calculated using SPSS v21.0 (SPSS Inc., Chicago, 
IL, USA).  For BOLD fMRI data, multiple regions of interest (ROI, Table 1) were 
selected using data provided in earlier pain fMRI work [3] as a guide and 
anatomically defined using the WFU PickAtlas (WFU Pickatlas, v2.4).  The 
PickAtlas ROI for mid-cingulum was modified based on earlier findings within this 
structure [20]. The sensory thalamus ROI was defined using FSL’s DTI-based 
segmentation of the thalamus.  The ROI corresponding to the foot representation 
within the primary somatosensory cortex has been defined previously.  From 
each atlas defined ROI, the mean BOLD response defined in terms of parameter 
estimates were extracted from each subject and each scanning session.  ICCs of 
absolute agreement were then calculated using a two-way mixed model that 
provided a measure of consistency through a ratio of between subject variance to 
total variance [2].  This statistical practice has been also been used in recent 
work aiming to test the reliability of fMRI data [9].  In addition, CIs at a 95% 
confidence level were calculated for all VAS pain ratings and all ROI evaluated.     
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Table 1: Regions of interest for which evoked BOLD responses and test-
retest reliability were quantified during 40°C, 44°C and 7/10 thermal pain 
stimulation paradigms.  Quantification was performed in left and right 
components of each ROI unless specified otherwise.  *Quantification of metrics 
from the primary somatosensory cortex was restricted to the right hemisphere 
(contralateral to stimulation site) and foot representation. 
     
 
Regions of Interest 
Amygdala Inferior Frontal Triangular  
Anterior Cingulate Middle Frontal 
Anterior Insula Middle Frontal Orbitalis  
Caudate Middle-Anterior Cingulate  
Cerebellum Crust I Middle-Posterior Cingulate   
Cerebellum Crust II Nucleus Accumbens 
Cerebellum III Posterior Cingulate  
Cerebellum IV & V Posterior Insula 
Cerebellum IX Primary Somatosensory Cortex (right)* 
Cerebellum VI Putamen 
Cerebellum VIIb Sensory Thalamus (bilateral) 
Cerebellum VIII Superior Frontal 
Cerebellum X Superior Frontal Orbitalis (left) 
Hypothalamus Superior Medial Frontal 
Inferior Frontal Opercularis  Supplemental Motor Area 
Inferior Frontal Orbitalis Thalamus 
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RESULTS 
 
 
Subjective Pain Ratings 
 
During fMRI experimentation, participants rated their subjective pain experience 
felt during each heat stimuli on a VAS pain scale (0 = no pain and 10 = maximal 
pain).  The group-average pain ratings validated that 40°C, 44°C and 7/10 heat 
stimuli would respectively be non-noxious, mildly noxious and noxious (Table 2). 
A significant difference between the VAS ratings of pain intensity for the three 
temperatures was found (p<0.05; ANOVA).  As expected, the 40°C stimulus and 
7/10 heat stimuli were predominately reported as being non-noxious and 
noxious, respectively. Moreover, CIs at the 95% confidence level demonstrated 
similar magnitudes of lower and upper CI bounds across the three thermal 
stimulation types.  
 
Test-retest reliability for VAS pain ratings for each temperature was obtained by 
calculating ICC values between scans 1 and 2 (Table 2).  For the 44°C and 7/10 
heat pain stimuli, ICC between scans 1 and 2 were high, while significant ICC 
was not observed for the 40°C.  The latter was believed to result from little or no 
pain being perceived and reported by healthy subjects. The ICC stemming from 
the 7/10 subjective pain rating was the highest ICC value obtained in this study. 
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Table 2: Summary of subjective reports obtained during 40°C, 44°C and 
7/10 thermal pain stimulation paradigms.  VAS pain ratings are given in terms 
of mean ± SE.  CIs are reported at the 95% confidence level.  *Indicates no test-
retest reliability between scans 1 and 2. SE – Standard Error; ICC – Intraclass 
Correlation Coefficient; CI – Confidence Interval   
 
 
 
Stimulation Scan Number 
VAS 
Mean ICC 
F 
value 
P-
value 
CI 
Lower 
CI 
Upper 
40°C 1 0.34 ± 0.4 -0.308* 0.762 0.654 -1.254 0.460 2 0.74 ± 1.0 
44°C 1 2.21 ± 1.4 0.860 7.787 0.003 -1.240 0.275 2 2.70 ± 1.7 
7/10 
1 7.18 ± 2.3 
0.938 15.694 0.001 -1.089 0.477 
2 7.48 ± 2.1 
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Single-subject, VAS responses corresponding to 40°C, 44°C and 7/10 heat 
stimuli are shown in Figure 1.  While no significant correlation in behavioral pain 
responses between scans 1 and 2 were observed, significant correlation and 
reproducibility in pain ratings were measured for both 44°C and 7/10 heat stimuli.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!13 
 
Figure 1: Single Single-subject evoked VAS pain ratings.  Single-subject pain 
ratings for 40°C, 44°C and 7/10 pain stimuli for scans 1 and 2 are given in scatter 
plot format.  Greater reproducibility at the single-subject level can be ascertained 
from data points projected closer to the centerline possessing a slope of 1.  
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QA of MRI Data 
All fMRI data surpassed the fBIRN QA procedure.  However, upon inspection of 
motion correction results, data from 2 of the 12 subjects was observed to have 
head motion greater than the in-plane resolution utilized during fMRI data 
acquisition.  VAS pain rating and BOLD fMRI results provided and discussed 
correspond to an N=10 dataset.  
 
Early and Late Phase Evoked BOLD Responses  
Similar to VAS pain rating data, statistical BOLD activation maps corresponding 
to early (Figure 2A) and late (Figure 2C) phase BOLD responses showed an 
overall pattern of increased activation when progressing from 40°C, 44°C and 
7/10 heat stimuli.  This progression was clearly observed in cortical (insula) and 
deeper subcortical (striatum) structures within the supraspinal pain processing 
pathways.  To further elucidate the behavior of pain processing CNS structures 
during early and late phase evoked BOLD responses, parameter estimates from 
the anterior insula (bilateral, atlas defined) were extracted and averaged across 
subjects and scanning sessions.  Interestingly, while a graded group average 
response was detected in the early phase within the anterior insula (Figure 2B), 
the anterior insula’s late phase response (Figure 2D) there was no measurable 
response for the 40°C and 44°C stimuli and a significant BOLD response was 
detected for the 7/10 heat pain stimuli.       
!!
 
Figure 2:  Group-average evoked BOLD responses to 40°C, 44°C and 7/10 pain stimulation.  Within group 
average response were obtained by combining fMRI data across all subjects (n=10) as well as across scan 
sessions 1 and 2.  Statistical maps obtained from mixed-effects analyses (z > 2.3 and cluster size corrected) are 
shown for each stimulation type and for early (A.) and late phase (B.) BOLD responses.  Summary statistics 
extracted from the anterior insula show a graded response during the early phase (C.).  The ANOVA test for the 
anterior insula, early phase BOLD responses revealed significant between condition differences (F2,57 = 19.88, p = 
2.88E-07).  Late phase BOLD responses in the anterior insula (D.) showed little or no response during the 40°C 
and 44°C stimulation, while the 7/10 pain stimulation was comparably more robust. The ANOVA test revealed 
significant between condition differences (F2,57 = 3.42, p = 0.04).   
15!
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Figure 2 continued:  Group-average evoked BOLD responses to 40°C, 44°C and 7/10 pain stimulation.  
Within group average response were obtained by combining fMRI data across all subjects (n=10) as well as across 
scan sessions 1 and 2.  Statistical maps obtained from mixed-effects analyses (z > 2.3 and cluster size corrected) 
are shown for each stimulation type and for early (A.) and late phase (B.) BOLD responses.  Summary statistics 
extracted from the anterior insula show a graded response during the early phase (C.).  The ANOVA test for the 
anterior insula, early phase BOLD responses revealed significant between condition differences (F2,57 = 19.88, p = 
2.88E-07).  Late phase BOLD responses in the anterior insula (D.) showed little or no response during the 40°C 
and 44°C stimulation, while the 7/10 pain stimulation was comparably more robust. The ANOVA test revealed 
significant between condition differences (F2,57 = 3.42, p = 0.04).  
16!
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Figure 3: Single-subject evoked BOLD responses to 7/10 pain stimulation.  
Single-subject early (A.) and late (B.) phase BOLD responses (defined by 
parameter estimates) for scans 1 and 2 are given in scatter plot format.  Greater 
reproducibility at the single-subject level can be ascertained from data points 
projected closer to the centerline possessing a slope of 1. Parameter estimates 
were extracted from atlas defined cortical and subcortical ROIs.  Corresponding 
ICC values for each ROI have been given in Table 3C.                 
!18 
 
Figure 2 continued: Single-subject evoked BOLD responses to 7/10 pain 
stimulation.   Single-subject early (A.) and late (B.) phase BOLD responses 
(defined by parameter estimates) for scans 1 and 2 are given in scatter plot 
format.  Greater reproducibility at the single-subject level can be ascertained 
from data points projected closer to the centerline possessing a slope of 1. 
Parameter estimates were extracted from atlas defined cortical and subcortical 
ROIs.  Corresponding ICC values for each ROI have been given in Table 3C.    
  
!19 
Single-subject, BOLD responses within cortical and subcortical ROIs as well as 
between scans 1 and 2 were evaluated for the 7/10 heat pain stimuli (Figure 3).  
Overall, across CNS structures and subjects good reliability can be visually 
observed with regards to the magnitude of the early (Figure 3A) and late (Figure 
3B) phase BOLD responses.  A comparison across the structures evaluated 
demonstrates higher consistency of BOLD responses between the two scan 
sessions for structures such as the anterior insula (early phase) and posterior 
cingulate (late phase) and lower consistency for the primary somatosensory 
cortex (late phase).  To detect significant differences in early and late phase 
BOLD responses between scans 1 and 2, paired comparisons were performed 
for each of the three heat stimulation paradigms.  The results of the paired, t-
tests are summarized in Tables 3-5.  
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Table 3: Regions with significant differences (paired, t-test, z > 2.3 and 
cluster size corrected) in early and late phase BOLD responses to 40°C heat 
stimulation between scans 1 and 2. 
Brain&Region& Lat.& z/stat& X(mm)& Y(mm)& Z(mm)& Vol(cm)&
Early&Phase&
Frontal& ! ! ! ! ! !
Frontal!Pole! R! 3.4839! 46! 48! 222! 0.648!
Inferior!Orbital! R! 3.4545! 36! 40! 220! 1.112!
Inferior!Triangular! L! 3.7205! 254! 18! 24! 0.752!
Inferior!Operculum! L! 3.1722! 252! 16! 18! 0.880!
Precentral! L! 2.9709! 260! 0! 26! 0.424!
Planum!Polare! R! 3.0661! 42! 22! 218! 0.560!
Parietal& ! ! ! ! ! !
Postcentral! L! 2.8821! 256! 0! 14! 0.376!
! L! 3.1526! 264! 28! 22! 0.472!
! L! 3.1302! 260! 28! 30! 0.552!
! L! 3.1912! 220! 242! 50! 0.400!
Occipital& ! ! ! ! ! !
Rolandic!Operculum! R! 3.1328! 60! 22! 16! 0.640!
! R! 3.3575! 60! 214! 12! 0.952!
! R! 2.9536! 44! 230! 18! 0.488!
Superior! R! 2.8929! 26! 270! 32! 0.456!
Temporal& ! ! ! ! ! !
Middle! R! 3.4461! 60! 4! 220! 0.856!
! L! 3.7127! 254! 232! 4! 0.472!
! R! 3.1961! 64! 238! 2! 0.520!
Temporal! L! 2.8518! 234! 2! 220! 0.616!
Superior! L! 3.1074! 264! 214! 10! 0.480!
! R! 4.0583! 62! 222! 2! 0.552!
Inferior!! R! 3.3370! 52! 232! 230! 0.440!
Insula& ! ! ! ! ! !
Insular!Cortex! L! 3.2601! 238! 218! 26! 0.528!
Late!Phase!
Occipital& ! ! ! ! ! !
Calcarine! L! 3.0880! 2! 288! 28! 0.400!
Brainstem&/&
Cerebellum& ! ! ! ! ! !
Cerebellum!Crust!II! R! 3.3060! 36! 274!
2
40! 0.872!
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Table 4: Regions with significant differences (paired, t-test, z > 2.3 and 
cluster size corrected) in early and late phase BOLD responses to 44°C heat 
stimulation between scans 1 and 2. 
!
Brain&Region& Lat.& z/stat& X(mm)& Y(mm)& Z(mm)& Vol(cm)&
Early&Phase&
Frontal& ! ! ! ! ! !
Superior! L! 3.3892! 228! 66! 0! 1.224!
Parietal& ! ! ! ! ! !
Inferior! L! 3.5494! 250! 234! 48! 0.928!
!! R! 3.1249! 58! 254! 42! 0.456!
Late&Phase&
Frontal& ! ! ! ! ! !
Precentral! L! 3.6118! 222! 228! 58! 0.792!
Parietal& ! ! ! ! ! !
Precuneus! R! 3.1607! 6! 252! 74! 0.416!
Occipital& ! ! ! ! ! !
Middle! L! 3.3052! 236! 272! 4! 0.672!
Cuneus! R! 3.4681! 18! 274! 36! 0.728!
! R! 3.0509! 10! 288! 38! 0.584!
Lateral!! L! 3.3172! 250! 274! 22! 0.912!
Superior! L! 3.6403! 214! 280! 42! 4.08!
! R! 3.5776! 26! 288! 30! 0.664!
Temporal& ! ! ! ! ! !
Lingual! L! 3.473! 212! 258! 28! 0.784!
! L! 3.5137! 212! 262! 210! 0.48!
Brainstem&/&
Cerebellum& ! ! ! ! ! !
Cerebellum!VI! L! 3.443! 216! 258! 216! 0.528!
! R! 3.2323! 16! 264! 214! 0.408!
! L! 3.4642! 210! 268! 218! 1.288!
Vermis!IV!&!V! !! 3.3084! 4! 260! 28! 1.824!
!
!
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Table 5: Regions with significant differences (paired, t-test, z > 2.3 and 
cluster size corrected) in early and late phase BOLD responses to 7/10 heat 
stimulation between scans 1 and 2. 
!
Brain&Region& Lat.& z/stat& X(mm)& Y(mm)& Z(mm)& Vol(cm)&
Early&Phase&
Brainstem&/&
Cerebellum& & & & & & &
Cerebellum!VI! L! 3.2968! 224! 262! 222! 0.824!
Late&Phase&
Frontal& & & & & & &
Superior! R! 3.4929! 4! 62! 16! 0.520!
! R! 3.3079! 14! 62! 8! 0.560!
! R! 3.4968! 6! 60! 24! 0.432!
! R! 3.3122! 8! 56! 32! 0.376!
! L! 3.4071! 210! 56! 34! 0.504!
! R! 3.4394! 14! 52! 26! 1.096!
! L! 3.2195! 218! 44! 36! 1.312!
! L! 3.2103! 222! 16! 58! 0.416!
Superior!Medial! L! 3.5368! 0! 62! 30! 0.408!
! L! 3.3261! 214! 62! 10! 0.616!
! L! 3.3021! 26! 60! 28! 0.432!
Middle!Orbital! R! 3.4895! 34! 58! 0! 1.024!
! R! 3.3259! 28! 4! 50! 0.464!
Middle! L! 3.2574! 228! 58! 16! 0.696!
! L! 3.2254! 232! 20! 28! 0.688!
Superior!Orbital! L! 3.3075! 228! 52! 24! 0.488!
! R! 3.2654! 20! 30! 42! 0.416!
! R! 3.2616! 20! 18! 54! 0.384!
Frontal!Pole! L! 3.4894! 220! 46! 28! 0.504!! !
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Table 5: Regions with significant differences (paired, t-test, z > 2.3 and 
cluster size corrected) in early and late phase BOLD responses to 7/10 heat 
stimulation between scans 1 and 2. !
Parietal& ! ! ! ! ! !
Postcentral! L! 3.2773! 234! 222! 50! 0.896!
SupraMarginal! R! 3.5677! 68! 242! 24! 0.376!
Precuneus! R! 3.3792! 4! 254! 26! 1.016!
! R! 3.4292! 8! 266! 46! 0.640!
! R! 3.2178! 8! 270! 50! 0.600!
Occipital! ! ! ! ! ! !
Inferior! R! 3.2428! 42! 274! 216! 0.416!
! L! 3.4305! 252! 2! 236! 0.640!
! L! 3.4108! 256! 228! 224! 0.672!
Temporal! ! ! ! ! ! !
Middle! L! 3.9546! 262! 24! 228! 1.008!
! L! 3.2570! 262! 214! 26! 0.408!
Cingulum& ! ! ! ! ! !
Anterior! R! 3.2600! 6! 50! 10! 0.384!
! L! 3.2653! 22! 34! 6! 0.584!
Cingulate!Gyrus! L! 3.3282! 210! 38! 6! 0.816!
! L! 3.2989! 2! 240! 22! 0.752!
Posterior! L! 3.3007! 22! 250! 26! 0.632!
Brainstem&/&
Cerebellum& ! ! ! ! ! !
Cerebellum!IX! L! 3.2448! 210! 248! 244! 0.472!
! R! 3.3085! 6! 254! 248! 0.432!
Vermis!IX! ! 3.3567! 0! 252! 234! 0.392!
!! !! 3.7068! 0! 262! 242! 0.712!
!
 
 
  
!24 
ICC Values and CI for Evoked BOLD Responses 
ICCs were quantified across all ROIs noted in Table 1 and for the three heat 
stimulation conditions, 40°C, 44°C and 7/10 heat stimuli (Table 3).  Very few 
CNS structures surpassed the p < 0.05 threshold (corresponding to ICC of ~ 0.5) 
for the 40°C (Table 3A, 3B) or 44°C (Table 3C, 3D) experimental conditions.  
Moreover, the ICC values for 40°C and 44°C stimuli ranged from 0.520 - 0.682.  
In sharp contrast, the 7/10 heat pain stimuli (Table 3E, 3F) yielded a substantially 
greater number of CNS structures surpassing the p < 0.05 threshold (ICC range: 
0.515 - 0.859) for both early and late phase BOLD responses.   
 
Table 6: ICC values and CIs across ROIs possessing a p value of 0.05 and 
lower.  ICCs and CIs were calculated for early and late phase evoked BOLD 
responses for 40°C (A. Early Phase, B. Late Phase.), 44°C (C. Early Phase, D. 
Late Phase.) and 7/10 (E. Early Phase, F. Late Phase.) thermal pain stimulation.  
CIs are reported at the 95% confidence level.   
 
A. 40°C Early Phase 
Regions of Interest ICC  F-value  
P-
value 
CI 
Lower 
CI 
Upper 
Thalamus (right) 0.643 4.119 0.023 -9.479 10.210 
 
B. 40°C Late Phase 
Regions of Interest ICC  F-value  
P-
value 
CI 
Lower 
CI 
Upper 
Superior Frontal (left) 0.575 5.606 0.009 1.590 14.252 
Cerebellum VI (right) 0.615 4.298 0.020 -3.239 10.018 
Cerebellum Crust I (right) 0.532 3.291 0.045 -5.427 14.514 
Supplementary Motor 
Area (left) 0.580 3.715 0.032 -7.576 17.669 
Sensory Thalamus 0.627 4.159 0.023 -3.802 6.721 
Thalamus (right) 0.614 4.441 0.018 -3.071 12.037 
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Table 6 continued: ICC values and CIs across ROIs possessing a p value of 
0.05 and lower.  ICCs and CIs were calculated for early and late phase evoked 
BOLD responses for 40°C (A. Early Phase, B. Late Phase.), 44°C (C. Early 
Phase, D. Late Phase.) and 7/10 (E. Early Phase, F. Late Phase.) thermal pain 
stimulation.  CIs are reported at the 95% confidence level.   
 
 
 
C. 44°C Early Phase 
Regions of Interest ICC  F-value  
P-
value 
CI 
Lower 
CI 
Upper 
Inferior Frontal Triangular (right) 0.552 3.252 0.047 -9.506 13.161 
Inferior Frontal Opercularis 
(right) 0.682 4.885 0.014 -11.438 14.152 
Anterior Insula (right) 0.620 4.092 0.024 -19.850 10.500 
 !!
  
           
D. 44°C Late Phase 
Regions of Interest ICC  F-value  
P-
value 
CI 
Lower 
CI 
Upper 
Cerebellum VIII (right) 0.536 3.213 0.049 -5.309 10.628 
Cerebellum VIII (left) 0.546 3.296 0.045 -6.366 12.600 
Cerebellum X (left) 0.563 3.398 0.041 -10.032 16.464 
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Table 6 continued: ICC values and CIs across ROIs possessing a p value of 
0.05 and lower.  ICCs and CIs were calculated for early and late phase evoked 
BOLD responses for 40°C (A. Early Phase, B. Late Phase.), 44°C (C. Early 
Phase, D. Late Phase.) and 7/10 (E. Early Phase, F. Late Phase.) thermal pain 
stimulation.  CIs are reported at the 95% confidence level.   
 
 
E. 7/10 VAS Pain Rating  Early Phase 
Region of Interest  ICC F-value P-value 
CI 
Lower CI Upper 
Medial Superior Frontal (left) 0.556 3.282 0.046 -19.423 14.487 
Medial Superior Frontal (right) 0.515 2.909 0.064 -13.836 14.654 
Superior Frontal (left) 0.642 4.240 0.021 -10.093 11.270 
Superior Frontal (right) 0.637 4.338 0.020 -10.696 5.535 
Superior Frontal Orbitalis (left) 0.773 7.386 0.003 -17.986 10.261 
Inferior Frontal Orbitalis (left) 0.787 7.796 0.003 -7.546 11.020 
Inferior Frontal Orbitalis (right) 0.625 4.362 0.019 -11.203 4.176 
Anterior Insula (left) 0.657 5.014 0.012 -12.674 3.834 
Anterior Middle Cingulate (left) 0.748 7.490 0.003 -25.797 6.222 
Anterior Middle Cingulate (right) 0.646 5.697 0.008 -28.793 1.971 
Supplemental Motor Area (left) 0.585 3.656 0.033 -27.117 15.050 
Supplemental Motor Area (right) 0.566 3.735 0.031 -29.396 8.858 
Inferior Frontal Opercularis (right) 0.706 7.668 0.003 -21.464 0.252 
Putamen (left) 0.568 3.402 0.041 -11.492 8.118 
Sensory Thalamus (Bilateral) 0.715 5.661 0.008 -8.450 5.225 
Posterior Middle Cingulate (left) 0.648 4.449 0.018 -15.646 9.053 
Posterior Middle Cingulate (right) 0.695 5.644 0.008 -16.453 5.797 
Posterior Insula (left) 0.715 5.805 0.008 -9.371 4.698 
Posterior Insula (right) 0.551 3.313 0.045 -13.932 7.769 
Hypothalamus (left) 0.489 3.273 0.046 -45.560 6.474 
Thalamus (left) 0.637 4.378 0.019 -12.957 6.254 
Thalamus (right) 0.726 7.430 0.003 -13.155 1.588 
Cerebellum IV & V (right) 0.823 9.532 0.001 -9.282 6.568 
Cerebellum IV & V (left) 0.675 4.958 0.013 -7.909 15.432 
Cerebellum VI (left) 0.619 3.924 0.027 -17.981 17.207 
Cerebellum VI (right) 0.578 3.472 0.039 -17.800 14.839 
Cerebellum VIIb (left) 0.750 6.556 0.005 -14.648 9.181 
Cerebellum VIIb (right) 0.644 4.294 0.020 -15.593 11.592 
Cerebellum VIII (left) 0.701 5.221 0.011 -13.742 12.159 
Cerebellum VIII (right) 0.708 5.366 0.010 -10.109 11.356 
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Table 6 continued: ICC values and CIs across ROIs possessing a p value of 
0.05 and lower.  ICCs and CIs were calculated for early and late phase evoked 
BOLD responses for 40°C (A. Early Phase, B. Late Phase.), 44°C (C. Early 
Phase, D. Late Phase.) and 7/10 (E. Early Phase, F. Late Phase.) thermal pain 
stimulation.  CIs are reported at the 95% confidence level.   
 
 
F. 7/10 VAS Pain Rating  Late Phase 
Region of Interest  ICC F-value P-value 
CI 
Lower CI Upper 
Amygdala (left) 0.724 5.796 0.008 -18.169 24.764 
Sensory Thalamus (Bilateral) 0.731 5.906 0.007 -9.158 10.161 
Posterior Middle Cingulate  (left) 0.559 3.419 0.041 -12.348 24.559 
Posterior Insula (left) 0.665 4.618 0.016 -9.478 12.579 
Thalamus (left) 0.633 4.163 0.023 -12.246 18.051 
Thalamus (right) 0.649 4.413 0.019 -16.370 10.784 
Primary Somatosensory Cortex 
(right) 0.761 6.908 0.004 -19.523 31.063 
Posterior Cingulate (left) 0.623 5.019 0.012 -4.245 34.890 
Posterior Cingulate (right) 0.812 9.813 0.001 -9.051 26.390 
Cerebellum III (left) 0.587 3.568 0.036 -12.501 14.971 
Cerebellum IV & V (left) 0.744 6.302 0.006 -13.191 9.722 
Cerebellum IV & V (right) 0.759 6.712 0.005 -10.097 8.386 
Cerebellum VI (left) 0.816 9.440 0.001 -18.293 9.608 
Cerebellum VI (right) 0.859 11.973 0.001 -10.926 10.592 
Cerebellum VIIb (left) 0.703 5.407 0.010 -14.726 9.057 
Cerebellum VIII (left) 0.835 10.207 0.001 -6.938 9.104 
Cerebellum VIII (right) 0.678 4.818 0.014 -9.773 12.435 
Cerebellum IX (left) 0.587 5.563 0.009 1.894 23.381 
Cerebellum IX (right) 0.678 4.818 0.014 -3.145 30.200 
Cerebellum X (right) 0.564 3.605 0.035 -11.967 32.231 
Cerebellum Crust I (left) 0.645 4.323 0.020 -24.706 17.437 
Cerebellum Crust I (right) 0.757 6.637 0.005 -17.112 19.650 
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When evaluating CIs at the 95% confidence level in relation to the corresponding 
ICC value, a relationship between the magnitudes of upper or lower CI bounds 
with ICC values was not observed.  Based on CIs, low variance was observed for 
early phase BOLD responses in structures such as the anterior and posterior 
insula, putamen and thalamus (including sensory thalamus), while higher 
variability was calculated for late phase BOLD responses such as the posterior 
cingulate and primary somatosensory cortex.  However, the magnitudes of CIs 
(lower and upper bounds) for early 
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DISCUSSION !
Summary of Findings !
The current study was design to reflect a standard randomized clinical trial and 
crossover design with drug and placebo.  The study assessed the graded, group-
level response and importantly, the test-retest reliability of VAS pain ratings and 
CNS BOLD responses measured during administration of three, evoked thermal 
stimulations; 40°C, 44°C and a subject-specific temperature eliciting a subjective 
pain level of 7/10.  Based on ICC values calculated between two scanning 
sessions and across study endpoints, reproducibility was observed to be highest 
for VAS pain ratings obtained during the 7/10 pain stimulation (ICC = 0.938).  
This could change significantly once similar work is carried out in patient 
populations rather than in healthy subjects. 
 
With respect to test-retest reliability of pain fMRI data, the 7/10 pain stimuli also 
yielded the greatest number of CNS structures possessing ICC levels of ~0.5 or 
more (p < 0.05; ICC range: 0.5 - 0.859).  For all VAS pain ratings and BOLD fMRI 
data points surpassing the threshold of p < 0.05/ICC of ~0.5, CIs were also 
calculated.  In future trials where an analgesic might be evaluated in healthy 
male subjects; the upper and lower CI bounds could be utilized to determine the 
magnitude of therapeutic effect necessary to overcome inherent variability of 
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either VAS pain ratings or BOLD responses evoked during innocuous or noxious 
thermal stimulation.  
 
Comparison of Pain fMRI Test-Retest Results !
Similar to previous investigations measuring test-retest reliability of pain fMRI 
measures [9; 14; 18], ICC values of BOLD responses evoked during noxious 
thermal stimulation were calculated across CNS structures.  A common theme 
amongst studies was the fact that high ICC values within BOLD fMRI data 
collected during noxious conditions were observed in sub-regions within the 
cingulate, insular and frontal cortices.  For example, for the anterior middle 
cingulate cortex, the current study, Letzen et al. and Quinton et al. all observed 
ICCs between ~0.7 and ~0.8 [9; 14].  Further congruence in terms of ICCs for 
BOLD fMRI data may have been present between this and past studies; 
however, in earlier work, the CNS ROIs evaluated did not include regions such 
as the amygdala, striatum or cerebellum.  One notable difference between the 
work by Quinton et al., and this study pertains to the reproducibility of BOLD 
responses of ascending pain pathway structures (i.e., sensory thalamus and 
primary somatosensory cortex) during noxious stimulation.  While the earlier 
study found insignificant or low test-retest reliability within the thalamus or 
primary somatosensory cortex, we observed that early and late phase BOLD 
responses possessed ICC values of similar magnitude (0.7-0.75) to cingulate, 
insular and frontal cortices.  This disparity may arise as a result of 
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methodological differences such as how these ascending pain pathway 
structures were anatomically defined or statistical modeling procedures of BOLD 
fMRI data (See Below).  Moreover, in accord with Letzen et al., we observed 
higher intersession reliability for subjective pain ratings compared to evoked 
BOLD responses in general.   
 
The evaluation of VAS pain ratings and BOLD responses for a range of thermal 
stimuli of increasing pain intensity enabled a graded CNS BOLD response to be 
detected, but importantly, demonstrated that insignificant or low test-retest 
reliability was present for innocuous or mildly noxious thermal stimuli (i.e., 40°C 
and 44°C) compared to the 7/10 pain stimulus.  It cannot be simply concluded 
that compared to low, non-noxious temperatures, higher temperatures will 
conventionally yield higher reproducibility of BOLD fMRI data.  It is likely that 
while some individuals can withstand, for example, a 50°C stimuli, others may 
find this temperature too intense, possess head motion and subsequently 
introduce variability into the data.  Thus, as performed in this and earlier work, to 
obtained significant test-retest reliability of VAS pain ratings and BOLD fMRI 
data, it is necessary to have a balance between a noxious stimuli as defined by 
the subject or patient, which is intense enough to remain noxious between 2 or 
more scanning session, yet not noxious to the point where study volunteers may 
find the stimulation paradigm unbearable.          
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It is noted that comparing reproducibility results across pain fMRI investigations 
was not necessarily a straightforward process given methodological differences 
each study incorporated in terms of evoked pain stimulation paradigms, data 
acquisition and data analyses.  For example, the evoked thermal pain stimuli 
utilized by Quinton et al., were 48°C and a subject-specific heat stimuli yielding a 
50/100 VAS pain rating, while Letzen et al. used a ‘tolerated’ temperature 
between 43 and 51°C.  This is in contrast to the 7/10 subject-specific 
temperature utilized herein.  In the reports by Letzen et al. as well as Quinton et 
al. reliability of BOLD responses of early and late phase BOLD responses 
throughout the CNS were not assessed.  Given the differences of the explanatory 
variables used in GLM analyses of BOLD fMRI data, between-study differences 
in ICC values for a single CNS structure could arise strictly as a result of the 
analytical approach taken.  Nonetheless, when considering the reproducibility 
results reported across studies and in pain processing CNS structures (i.e., 
cingulate, insular and frontal cortices) what can be said with confidence is that 
sufficient intersession reliability exist for pain fMRI, such that the method can be 
implemented to evaluate CNS pain processing in longitudinal studies involving 
healthy subjects.  The utility of pain fMRI is further warranted when considering 
the work of Wager and colleagues, where an fMRI-based signature of pain 
demonstrated high sensitivity and specificity as well as treatment response [23].  
Interestingly, the fMRI signature of pain identified in the latter study consisted of 
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CNS structures such as the thalamus, insula and cingulate; structures that 
showed significant reproducibility in the past and current fMRI investigation.                  
 
Study Limitations !
Number of Scan Sessions:  
Intersession reliability of behavioral and fMRI data may vary based on the 
number of scan sessions used to assess methodological test-retest reliability. 
Previous studies have used a comparison of three scan sessions to determine 
reproducibility [9; 14].  In contrast, the design implemented in the current work 
was setup with a placebo-controlled, cross over study paradigm in mind, given its 
utility in trials evaluating pharmacological therapies.  Nonetheless, the inclusion 
of additional scanning sessions or a longer intersession time interval may enable 
a better evaluation of reliability and stability of behavioral and fMRI measures.    
 
Subjects:  
Compared to earlier trials investigating test-retest reliability of evoked pain fMRI, 
the cohort size of the present study was considered small (n=10). The univariate 
analysis results for BOLD fMRI data did indeed elicit the expected robust 
response within the supraspinal CNS structures mediated pain, particularly for 
the 7/10 pain stimulation.  However, with a larger study population, a more 
accurate account of variance for both pain ratings and BOLD fMRI data may be 
achieved.      
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The primary goal of this study was to evaluate the reproducibility of evoked pain 
methodology itself, and therefore, a ‘homogeneous’ population of healthy male 
subjects was enrolled.  Given the known differences in pain processing between 
males and females, the projection of the current results to a female population or 
a broader population encompassing both males and females should be done with 
caution [12] 
 
Habituation:  
As with most fMRI studies, including those investigating evoked pain responses, 
stimuli are often repeatedly presented in order to increase the SNR (signal to 
noise ratio) of the BOLD signal.  This repetition could induce a habituation effect, 
and in turn introduce variance into the data.  Here, each stimulus (40°C, 44°C 
and 7/10 heat stimuli) was repeated 5 times, but in a randomized manner. The 
randomization is believed to have minimized the risk of habituation to any one 
particular stimulus as evidenced by the graded responses measured across the 
three stimuli as well as the group-average pain rating of ~7 obtained for the 7/10 
pain stimulus.  However, a complete negation of habituation would be difficult. 
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Future Directions !
A key step to further understanding the benefits and limitations of pain fMRI 
measures is to utilize the technique in a longitudinal manner in a pain patient 
population. In patients, fluctuations in disease specific pain, from magnitude, 
location and frequency perspectives, as well as other related disease factors 
(e.g., fatigue, depression or frequency of medications consumed) can be present 
across time.  To what extent these patient-specific fluctuations impact the 
reliability and reproducibility of measures obtained in an fMRI study are in large 
part unknown.  Moreover, by implementing pain fMRI longitudinally in patients, if 
and how fMRI measures track with core symptoms, which are of key clinical 
interest during therapeutic evaluation, may also be quantitatively understood.  It 
may be the case that the natural waxing and waning of endogenous pain levels 
or other symptoms may introduce variability and thus lessen intersession test-
retest reliability of evoked pain endpoints.  However, it may be of value to 
elucidate the underlying pathophysiology of pain or symptom fluctuation in 
patients, as the former could be easier to target within the translational medicine 
setting.   
 
In patients, much is unknown regarding how much potentiation or attenuation of 
the BOLD response measured in a CNS structure or network is necessary to 
overcome the inherent variance as well as to induce a meaningful clinical effect.  
By longitudinally measuring the pharmacodynamics of a standard of care for a 
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specific pain patient population, the magnitude of effect and its clinical relevance 
can be better realized.  Given the diverse functional, structural and 
neurochemical changes that can be present between distinct pain conditions, it is 
likely that a single answer does not exists in terms how and what CNS brain 
region(s) should be therapeutically targeted.   
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